RenMab™ Mouse Platform Drives SARS CoV-2 Neutralizing Antibody Cocktail Therapy Towards Clinical Trials in Biocytogen and Eucure Biopharma Partnership
[MA, USA and Beijing, China - August] The COVID-19 pandemic has been an inescapable, lethal, and overwhelming aspect of daily human life, threatening health and…
Read more
Webinar: Antibody Discovery Platforms and RenMab Mouse
Biocytogen Chief Scientific Officer and Head of Drug Discovery, Benny Yang PhD. will speak on the current landscape of antibody discovery platforms, with special focus on fully human antibody mice. Dr. Yang will explain…
Read more
Webinar: Humanized Animal Models for Immunotherapy
This event has now passed. Now, you can view the Webinar on Youtube. Topic: Improve Translation of Humanized Animal Models for Immunotherapy Date: Thursday,…
Read more
Syngeneic Mouse Models and Humanized Immune-Checkpoint Mice
Why do we need Syngeneic Mouse Models? To test potential immuno-oncology therapeutics in vivo, it is necessary to ensure that the disease model used has…
Read more
Online: Tumor Models Boston Summit 2020
In Vivo Efficacy & Toxicity Evaluation Using Various Humanized Mouse Models to Increase Clinical Translation Time: Saturday, July 15 2020. 9:30 AM EST. Speaker: Qingcong Lin,…
Read more
AACR Virtual Annual Meeting II (Poster Session)
The AACR Foundation is the philanthropic arm of the American Association for Cancer Research (AACR). The Foundation supports the groundbreaking work of the AACR and…
Read more
Biocytogen is Featured in GEN’s Immunotherapy and Cancer Supplement Issue
Developing animal models for immunotherapy is often difficult due to the complexity of the immune system and tumor biology. Showcased in April’s GEN Magazine, Biocytogen…
Read more
Biocytogen CEO’s Response During COVID-19 Pandemic
Dear Valued Customer, The COVID-19 global outbreak has undoubtedly brought upon difficult times for individuals, families, and businesses around the world. Many of us have…
Read more
Biocytogen Announces Dr. Zhaoxue (Luke) Yu as Global Head of Preclinical Pharmacology
On March 31st, Biocytogen announced Dr. Zhaoxue (Luke) Yu as our Global Head of Preclinical Pharmacology. As our global preclinical pharmacology team leader, Dr. Yu…
Read more
Gene Targeting Service Verified with Industry-leading Quality Control Measures
At Biocytogen, we take pride in our quality control measures when we target and edit genes for our mouse models and drug development endeavors.…
Read more